MFG-E8 Is Critical for Embryonic Stem Cell-Mediated T Cell Immunomodulation.

Area of Science:

• Immunology
• Stem Cell Biology
• Transplantation Science

Background:

• The low immunogenicity of undifferentiated embryonic stem cells (ESCs) is not fully understood.
• Identifying molecules that mediate immune tolerance in ESCs is crucial for therapeutic applications.

Purpose of the Study:

• To investigate the role of milk fat globule epidermal growth factor 8 (MFG-E8) in the immune privilege of ESCs.
• To elucidate the mechanisms by which MFG-E8 influences T cell responses and transplantation outcomes.

Main Methods:

• Assessed MFG-E8 expression in undifferentiated and differentiated ESCs.
• Evaluated the impact of MFG-E8 on T cell activation, proliferation, and polarization in vitro.
• Studied the effect of MFG-E8 on ESC engraftment across major histocompatibility complex barriers in vivo.
• Investigated the signaling pathway involving MFG-E8, α3/5βV integrin, and PKCθ phosphorylation.

Main Results:

• MFG-E8 is enriched in undifferentiated ESCs and its upregulation enhances ESC engraftment across MHC barriers.
• MFG-E8 suppresses T cell activation, proliferation, and Th1/Th2/Th17 responses while promoting regulatory T cells.
• Neutralizing MFG-E8 reverses these immunosuppressive effects; recombinant MFG-E8 restores them.
• MFG-E8 inhibits T cell activation and polarization by downregulating PKCθ phosphorylation via the α3/5βV integrin receptor.

Conclusions:

• MFG-E8 is a key mediator of ESC immune privilege by directly suppressing T cell responses.
• MFG-E8 regulates T cell polarization through the α3/5βV integrin-PKCθ pathway.
• Targeting MFG-E8 presents a promising strategy to improve the acceptance of ESC transplantation.